BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

30 related articles for article (PubMed ID: 2809902)

  • 1. Effect of Weekly Long-Acting Growth Hormone Replacement Therapy Compared to Daily Growth Hormone on Children With Short Stature: A Meta-Analysis.
    Ma L; Li L; Pan W; Huang C; Liu L; Zhang X
    Front Endocrinol (Lausanne); 2021; 12():726172. PubMed ID: 34912293
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Factors affecting bone age maturation during 3 years of growth hormone treatment in patients with idiopathic growth hormone deficiency and idiopathic short stature: Analysis of data from the LG growth study.
    Kang MJ; Kim EY; Shim YS; Jeong HR; Lee HJ; Yang S; Hwang IT
    Medicine (Baltimore); 2019 Apr; 98(14):e14962. PubMed ID: 30946320
    [TBL] [Abstract][Full Text] [Related]  

  • 3. High dose growth hormone treatment induces acceleration of skeletal maturation and an earlier onset of puberty in children with idiopathic short stature.
    Kamp GA; Waelkens JJ; de Muinck Keizer-Schrama SM; Delemarre-Van de Waal HA; Verhoeven-Wind L; Zwinderman AH; Wit JM
    Arch Dis Child; 2002 Sep; 87(3):215-20. PubMed ID: 12193430
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of a pen injector system for growth hormone treatment.
    Gluckman PD; Cutfield WS
    Arch Dis Child; 1991 Jun; 66(6):686-8. PubMed ID: 2053787
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prepubertal height velocity references over a wide age range.
    Rikken B; Wit JM
    Arch Dis Child; 1992 Oct; 67(10):1277-80. PubMed ID: 1444528
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Idiopathic short stature: management and growth hormone treatment.
    Wit JM; Reiter EO; Ross JL; Saenger PH; Savage MO; Rogol AD; Cohen P
    Growth Horm IGF Res; 2008 Apr; 18(2):111-35. PubMed ID: 18178498
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long-term results of growth hormone therapy in children with short stature, subnormal growth rate and normal growth hormone response to secretagogues. Dutch Growth Hormone Working Group.
    Wit JM; Boersma B; de Muinck Keizer-Schrama SM; Nienhuis HE; Oostdijk W; Otten BJ; Delemarre-Van de Waal HA; Reeser M; Waelkens JJ; Rikken B
    Clin Endocrinol (Oxf); 1995 Apr; 42(4):365-72. PubMed ID: 7750190
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A controlled trial of methionyl growth hormone therapy in prepubertal children with short stature, subnormal growth rate and normal growth hormone response to secretagogues. Dutch Growth Hormone Working Group.
    Wit JM; Rietveld DH; Drop SL; Oostdijk W; Gons M; Otten BJ; Delemarre-van de Waal HA; Reeser M; Waelkens JJ; Bot A
    Acta Paediatr Scand; 1989 May; 78(3):426-35. PubMed ID: 2662700
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Growth response of children with non-growth-hormone deficiency and marked short stature during three years of growth hormone therapy.
    Hopwood NJ; Hintz RL; Gertner JM; Attie KM; Johanson AJ; Baptista J; Kuntze J; Blizzard RM; Cara JF; Chernausek SD
    J Pediatr; 1993 Aug; 123(2):215-22. PubMed ID: 8345416
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of growth hormone on short normal children.
    Hindmarsh PC; Brook CG
    Br Med J (Clin Res Ed); 1987 Sep; 295(6598):573-7. PubMed ID: 3117236
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of two years of growth hormone treatment in short, slowly growing non-growth hormone deficient children.
    Lanes R
    J Pediatr Endocrinol Metab; 1995; 8(3):167-71. PubMed ID: 8521190
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of two years of methionyl growth hormone therapy in two dosage regimens in prepubertal children with short stature, subnormal growth rate, and normal growth hormone response to secretagogues. (Dutch Growth Hormone Working Group).
    Wit JM; Fokker MH; de Muinck Keizer-Schrama SM; Oostdijk W; Gons M; Otten BJ; Delemarre-Van de Waal HA; Reeser M; Waelkens JJ
    J Pediatr; 1989 Nov; 115(5 Pt 1):720-5. PubMed ID: 2809902
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Recombinant growth hormone in children and adolescents with Turner syndrome.
    Cave CB; Bryant J; Milne R
    Cochrane Database Syst Rev; 2003; (3):CD003887. PubMed ID: 12917993
    [TBL] [Abstract][Full Text] [Related]  

  • 14.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 15.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 2.